You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +43 (0)1 71 72 8 900 or email: apus@templetonapus.com |
|
Most viewed
- 1. FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
- 2. US FDA says possible carcinogen found in some Merck diabetes drugs
- 3. Olivia Newton-John's family indicates it would accept state funeral for Grease star
- 4. Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
- 5. Lymphedema: Living with Swelling and Stiffness
- 6. China Kidney Cancer Treatment Drugs Market Report 2022: Demand for Kidney Cancer Treatment Drugs will continue to grow at 8% by 2031 - ResearchAndMarkets.com
- 7. Beach Energy to supply LNG to BP, Imugene trials show ‘positive signals' and ANZ extends $200m funding program
- 8. Vancouver Researchers Suggest Air Pollution be Included as Risk Factor for Patients with Lung Cancer and Have Never Smoked
- 9. Informed Consent Forms for Lung Cancer Clinical Trials May be a Barrier to Informed Trial Participation
- 10. A mutated eye offers a glimpse of a key protein for preventing cancer
Last updated at 19:24 GMT
Hot News Makers
Health/Pharma Companies
-
66679.42
-
31656.25
-
28930.73
-
27468.51
-
16972.42
-
15976.58
-
13502.80
-
11508.49
-
11295.34
-
11192.17
Last updated at 19:10 GMT